Colonoscopy is heavily promoted in the VA healthcare system, and a new study sought to document its effect on colorectal cancer (CRC) mortality rates.
The standard of care for locoregionally advanced rectal cancer (LARC) in the United States usually involves adjuvant chemotherapy (AC) following chemoradiation (CRT) and total mesorectal excision (TME).
While suspected, the relationship between dietary and lifestyle risk factors and long-term mortality from colorectal cancer remains poorly understood, according to a new study.
Chances are, if you haven’t trained or practiced at the VA, you haven’t seen cutaneous T-cell lymphoma (CTCL), a form of non-Hodgkin lymphoma.
While the availability of novel therapies is making the future brighter for non-Hodgkin’s lymphoma (NHL) patients, new treatments also are coming on line for Hodgkin’s lymphoma, which is a hematological cancer distinct from NHL.
Because several studies have suggested it fails to increase overall survival (OS) despite prolonging progression-free survival (PFS), use of maintenance rituximab (MR) following chemoimmunotherapy in follicular lymphoma (FL) remains controversial.
Multiple organizations have recommended timely treatment for patients with lung cancer.
The treatment armamentarium for renal cell carcinoma and other genitourinary cancers continues to expand.
More than 95,000 Americans develop colon cancer, making it the third most common cancer in the U.S., excluding skin cancers.
While guidelines for multiple myeloma advise pharmacologic prophylaxis to prevent development of venous thromboembolism (VTE) in high-risk patients, current risk assessment tools differ in the factors considered indicative of high risk and in the patients determined to need preventive anticoagulation.
Researchers reported positive results today for phase IIb testing of a vaccine for high-risk melanoma patients.
Federal researchers reported updated results of trials of cabozantinib plus nivolumab with and without ipilimumab in patients with refractory metastatic urothelial carcinoma on Saturday at the 2018 American Society of Clinical Oncology Annual Meeting.
HOUSTON — For veterans with hepatocellular carcinoma (HCC), research presented today at the 2018 American Society of Clinical Oncology Annual Meeting in Chicago offers encouraging the news. The study determined that a new tyrosine kinase... View Article
Bleomycin, the first line standard of care for Hodgkin lymphoma causes pulmonary events in some patients, but physicians have been uncertain how many patients are affected and how long they remain at risk.
Assessing tumor growth and regression to determine a treatment’s efficacy over time can be challenging on an individual basis.
Vitamin D deficiency doesn’t just increase the risk of osteoporosis and other bone disorders, it dramatically increases the risk of death in older cancer patients with solid tumors, according to researchers at the Central Texas Veterans Healthcare System in Temple, and the University of Texas MD Anderson Cancer Center in Houston.
Physicians and patients want to do everything possible to minimize the risk of breast cancer recurrence without incurring unnecessary toxicity from chemotherapy.
For the physicians treating men with non-metastatic castration resistant prostate cancer, knowing the risk of progression or death provides valuable information to guide the timing and selection of treatment.
Despite limited evidence to support the practice, testing for Helicobacter pylori (Hp) infection is recommended for work-up of unexplained iron deficiency anemia (IDA).
SALT LAKE CITY — The presence of deletion 17p (del17), determined by chromosome analysis and/or fluorescence in situ hybridization (FISH), is a strong negative prognostic marker in chronic lymphocytic leukemia (CLL), according to a report in the Journal of Clinical Oncology.1
While increased use of stereotactic body radiation might have played a key role in doubling survival rates for early-stage non-small cell lung cancer (NSCLC) among veterans between 2001 and 2010 compared to conventional radiation, a new study confirms that isn’t always the best way to assure longer survival.
BEDFORD, MA—Active surveillance (AS) has been widely implemented at the VA as a standard of care for low-risk prostate cancer (PCa). A study in the American Journal of Managed Care posits, however, that patient characteristics such as... View Article
With growing concern about overtreatment of breast cancer as outcomes have improved over time, not much research has been performed on how chemotherapy use and oncologists' recommendations have changed in recent years.
Pancreatic cancer patients increasingly are receiving minimally invasive pancreaticoduodenectomy (MIPD).
Aggressive care for cancer patients appears to be increasing at the end of life, and the VA is part of that trend, according to a new study.
LEBANON, NH — Extracorporeal photopheresis (ECP) is a leukapheresis-based therapeutic procedure that has been approved by the Food and Drug Administration (FDA) for the treatment of advanced cutaneous T-cell lymphoma (CTCL) since 1988. In ECP,... View Article
STANFORD, CA — Patients with cutaneous T-cell lymphoma (CTCL) might have a promising new treatment option, according to a study presented at a recent conference. In a presentation at the 2017 American Society of Hematology... View Article
MINNEAPOLIS—Exposure to Agent Orange was not associated with either poor prognostic factors or shortened overall survival in a large veteran population with chronic lymphocytic leukemia (CLL), even though it is associated with development of the... View Article
Should stereotactic body radiotherapy remain the standard treatment for medically inoperable early-Stage non-small cell lung cancer?
BETHESDA, MD—Past research has raised the possibility that a common blood sugar-lowering drug could be associated with improved survival in cancer patients with Type 2 diabetes. A study published recently in the International Journal of Cancer assessed... View Article
Improved radiation and surgical techniques boosted overall survival in veterans diagnosed with Stage I non-small cell lung cancer (NSCLC) from 2001 to 2010.
DURHAM, NC—What is the association between lowest prostate-specific antigen (PSA) and time to nadir with biochemical recurrence (BCR) risk after radical prostatectomy (RP)? A study published recently in the journal Urology used the SEARCH database... View Article
DURHAM, NC—Visceral metastases (VMs) are generally believed to predict worse prognoses compared with bone and lymph metastases in men with metastatic castration-resistant prostate cancer (mCRPC). Still, a new study published in the journal European Urology... View Article
EAST NORTHPORT, NY—Being diagnosed with prostate cancer can be difficult enough. But what happens when the patient also is a veteran with post-traumatic stress disorder (PTSD)? A presentation at the 2017 American Society of Clinical... View Article
By Stephen Spotswood BALTIMORE—James Donahue, MD, has been thinking about the need for better treatments for cancer his entire adult life. His mother died from breast cancer when he was 14, and from that day... View Article
NEW YORK—A new study found higher rates of melanoma in users of the erectile dysfunction drug Viagra but could identify no direct cause and effect. A report published online by the Journal of the National... View Article
PORTLAND, OR — Not long ago, less than a third of chronic myeloid leukemia (CML) patients survived five years and gastrointestinal stromal tumor (GIST) patients had an even shorter life expectancy, according to the National Cancer Institute. Now significant numbers of patients with these cancers live for another 10 years after diagnosis.
Between 2001 and 2010, survival rates for early-stage non-small cell lung cancer (NSCLC) doubled among veterans.
While Dr. Watson of Sherlock Holmes fame often missed the critical clue, the VA expects its new partnership with IBM’s Watson to help it detect the genomic fingerprints of cancer and make effective treatments less of a mystery.
According to VHA rules, veterans with cancer need not make the “terrible choice” between receiving therapies to combat their illness or hospice services.
Recent research has focused on some etiological factors to help predict who is at risk for developing cutaneous T-cell lymphoma (CTCL), which occurs disproportionately in veterans.
The Institute of Medicine (IOM) changed the classification of three medical conditions in its last congressionally-ordered review of the evidence of health problems associated with exposure to Agent Orange and other herbicides during the Vietnam War.
ROCKVILLE, MD — While previous studies have reported that survivors of non-Hodgkin lymphoma (NHL) have an increased risk of developing cutaneous melanoma, risks associated with specific treatments and immune-related risk factors have not been quantified.To... View Article
SAN ANTONIO — New research directly links disrupted metabolism to a common and often fatal type of lymphoma, according to an article in Nature Communications.1“The link between metabolism and cancer has been proposed or inferred... View Article
By Stephen SpotswoodATLANTA — For patients diagnosed with a malignancy, the natural response is to ask the physician to do everything possible to treat the cancer.The challenge for VA clinicians and others, especially with older... View Article
With low-risk prostate cancer, aggressive treatment of some men leads to marginal survival benefits yet exposes them to urinary and sexual side effects.
LOUIS — New-onset diabetes mellitus (NODM) in adults can be an indicator of pancreatic cancer, although the incidence remains low in that cohort. A new study sought to determine whether other factors could help determine... View Article
NEW YORK — U.S. Air Force personnel who conducted aerial herbicide spray missions of Agent Orange during the Vietnam War had more than double the risk of monoclonal gammopathy of undetermined significance (MGUS), according to... View Article
In 2012, the National Comprehensive Cancer Network (NCCN), an alliance of leading cancer care centers, recommended that women with breast cancer be offered BRCA1/BRCA2 testing if they were 45 or younger or 50 or younger with a family history or an additional primary case.
BRONX, NY — Survival in veterans with lung cancer is more related to their percentage weight loss and stage of cancer than the subtype of lung cancer, according to a new study.Background in the article,... View Article
© 2000-2017. All Materials Copyright Marathon Medical Communications, Inc.